These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3396495)

  • 21. [Studies on the pharmacokinetics of cefotaxime in neonates].
    Nishimura T; Takashima T; Hiromatsu K; Tabuki K
    Jpn J Antibiot; 1982 Jul; 35(7):1793-800. PubMed ID: 6294360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potencies of ceftriaxone and cefotaxime in a single chamber pharmacokinetic system simulating their in vivo half-lives.
    Unowsky J; Sattler J; Patel IH
    Chemotherapy; 1989; 35(5):338-44. PubMed ID: 2676404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of cefotaxime in preterm infants.
    Gouyon JB; Pechinot A; Safran C; Chretien P; Sandre D; Kazmierczak A
    Dev Pharmacol Ther; 1990; 14(1):29-34. PubMed ID: 2311478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and penetration into tissue fluid of cefotaxime in bovines.
    Rule R; Buschiazzo H; Rubio M; Quiroga G; de Buschiazzo P
    Chemotherapy; 1994; 40(4):221-6. PubMed ID: 8082408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro simulated pharmacokinetics profiles: forecasting antibiotic optimal dosage.
    Firsov AA
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():406-9. PubMed ID: 1820913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of cefotiam in patients undergoing continuous ambulatory peritoneal dialysis].
    Itagaki N; Hasegawa H; Tsujino M; Takahashi K; Yamamoto Y; Imada A; Horiuchi A
    Jpn J Antibiot; 1988 Apr; 41(4):405-8. PubMed ID: 3165474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of cefotaxim in geriatric patients (author's transl)].
    Naber K; Adam D
    MMW Munch Med Wochenschr; 1980 Nov; 122(46):1651-4. PubMed ID: 6258061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of the mode of intravenous administration on cephotaxime concentration in bile. A comparison of bolus, drip infusion and bolus plus drip infusion.
    Miglioli PA; Tedeschi U
    Chemotherapy; 1988; 34(5):380-4. PubMed ID: 3180906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of the liver.
    Höffken G; Lode H; Koeppe P; Ruhnke M; Borner K
    Chemotherapy; 1984; 30(1):7-17. PubMed ID: 6319092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients.
    Mazzei T; Novelli A; Esposito S; Fallani S; Noviello S; Cassetta MI; Conti S; Periti P
    J Chemother; 2000 Aug; 12(4):306-13. PubMed ID: 10949980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of cefotaxime in sheep.
    Guerrini VH; Filippich L; English PB; Bourne DW
    Am J Vet Res; 1983 Aug; 44(8):1488-91. PubMed ID: 6312852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Claforan concentration in wound secretion following intravenous, intra-arterial, and regional intravenous infusion in patients with stage IV arterial occlusive diseases of the lower extremities].
    Acevedo A; Schoop W
    Vasa Suppl; 1991; 32():363-4. PubMed ID: 1771535
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of cefodizime in normal individuals and in patients with renal failure.
    el Guinaidy MA; Nawishy S; Abd el Bary M; Sabbour MS
    Chemotherapy; 1991; 37(2):77-85. PubMed ID: 2032473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cefotaxime in neonatal pony foals.
    Gardner SY; Sweeney RW; Divers TJ
    Am J Vet Res; 1993 Apr; 54(4):576-9. PubMed ID: 8484578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of cefotaxime and its desacetyl metabolite in plasma and in cerebrospinal fluid.
    Beyssac E; Cardot JM; Colnet G; Sirot J; Aiache JM
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):91-102. PubMed ID: 3691581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum concentrations of cefotaxime and its metabolite desacetyl-cefotaxime in infants and children during continuous infusion.
    Bertels RA; Semmekrot BA; Gerrits GP; Mouton JW
    Infection; 2008 Oct; 36(5):415-20. PubMed ID: 18791659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma and peritoneal concentration following continuous infusion of cefotaxime in patients with secondary peritonitis.
    Seguin P; Verdier MC; Chanavaz C; Engrand C; Laviolle B; Donnio PY; Mallédant Y
    J Antimicrob Chemother; 2009 Mar; 63(3):564-7. PubMed ID: 19168542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
    Höffler D; Koeppe P
    Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and distribution of single-dose preoperative antibiotic prophylaxis in high-risk gastroduodenal surgery.
    Lewis RT; Goodall RG; Marien B; Park M; Lloyd-Smith W; Wiegand FM
    Can J Surg; 1991 Apr; 34(2):117-22. PubMed ID: 2025800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.